OMER Competitors & Alternatives
Compare Omeros Corporation with similar stocks in the same industry
Biotechnology
OMER
Main Stock$18.22
Tradestie Score
38
Market Cap
$281.75M
P/E Ratio
11.7
Revenue Growth
0.1%
Analyst Upside
+81.1%
Top Competitors
242 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.54
|
$1.50B | 7.3 | 43 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$49.35
|
$1.50B | - | 43 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$37.08
|
$1.49B | - | 39 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$30.76
|
$1.43B | - | 35 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$18.89
|
$1.42B | - | 45 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$20.09
|
$1.35B | - | 59 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$52.50
|
$1.32B | - | 42 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$8.68
|
$1.29B | - | 46 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$33.09
|
$1.29B | - | 56 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.83
|
$1.29B | - | 73 | Compare |
More OMER Analysis
Data updated: Aug 26, 2026 | Industry: Biotechnology (SIC 2834)
242 stocks in this industry